Social Aspects of Drug Discovery Development and Commercialization 1st Edition by Odilia Osakwe, Syed Rizvi ISBN 0128022205 978-0128022207

Social Aspects of Drug Discovery Development and Commercialization 1st Edition by Odilia Osakwe, Syed Rizv – Ebook PDF Instant Download/Delivery:  0128022205, 978-0128022207
Full download Social Aspects of Drug Discovery Development and Commercialization 1st edition after payment

Product details:

ISBN 10: 0128022205
ISBN 13: 978-0128022207
Author:  Odilia Osakwe, Syed Rizvi

Social Aspects of Drug Discovery, Development and Commercialization provides an insightful analysis of the drug discovery and development landscape as it relates to society. This book examines the scientific, legal, philosophical, economic, political, ethical and cultural factors that contribute to drug development. The pharmaceutical industry is under scrutiny to develop safer and more effective drugs in a quicker and more affordable manner. Recent criticism and debates have emphasized varying opinions on the issues concerning the drug discovery and development process.

This book provides thoughtful and valuable discussions and analysis of the social challenges and potential opportunities through all stages of the pharmaceutical process, from inception through marketing. With a unique focus on the social factors that increasingly play a role in how drug development is planned, structured, and executed throughout the drug product lifecycle, this is an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society.

• Organized in a sequence of interrelated theories and principles that provide the foundation for increased understanding of the relevant social aspects
• Includes analysis of important new advances, key scientific and strategic issues, and overviews of recent progress in drug development
• Provides a global perspective with examples from developed areas, such as the US, Japan, Canada and Europe, as well as faster-growing and emerging economies including Brazil, Russia, India, and China
• Serves as an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society

Social Aspects of Drug Discovery Development and Commercialization 1st  Table of contents:

Section I: Pharmaceutical Industry, Society, and Governance

Chapter 1: Pharmaceutical Regulation: The Role of Government in the Business of Drug Discovery

Abstract

1.1. Introduction

1.2. The legal instruments

1.3. The National Regulatory Authorities and Administration

1.4. Analytical framework for regulatory approval: benefit–risk assessment

1.5. The pharmaceutical product life cycle

1.6. The global pharmaceutical industry: harmonization and partnerships

1.7. Modernization of the global pharmaceutical systems: regulatory strategies, roadmap initiatives, and partnerships

Chapter 2: Trends in Innovation and the Business of Drug Discovery

Abstract

2.1. Introduction

2.2. Evolutionary trends in pharmaceutical innovation

2.3. Advances in pharmaceutical innovation technology

2.4. Select medical milestones of 2014

2.5. Factors contributing to pharmaceutical innovation setback

2.6. Case: challenges in antimicrobial drug discovery

2.7. Consequence of innovation setback

2.8. Strategies and approaches to addressing innovation failure

2.9. Concluding remarks

Chapter 3: Cash Flow Valley of Death: A Pitfall in Drug Discovery

Abstract

3.1. Introduction

3.2. Product valuation as an investment decision-making tool

3.3. Challenges associated with the valley of death

3.4. Firms involved in the pharmaceutical value chain

3.5. Strategies for bridging the Valley of Death and innovation failure

3.6. Funding models

3.7. Nongovernmental funding models

3.8. Other financial concepts

3.9. Private–public sector groups

Section II: Drug Discovery Cycle I: Discovery and Preclinical Drug Development

Chapter 4: Prediscovery Research: Challenges and Opportunities

Abstract

4.1. Introduction

4.2. Models of human disease biology

4.3. Diseases considered in biopharmaceutical research and development

4.4. Modern trends in drug discovery

4.5. Current challenges in early drug discovery

Chapter 5: The Significance of Discovery Screening and Structure Optimization Studies

Abstract

5.1. Introduction

5.2. Screening tools in drug discovery

5.3. In silico models in drug discovery and design

5.4. From hit to lead: summary of compound optimization in drug discovery

Chapter 6: Preclinical In Vitro Studies: Development and Applicability

Abstract

6.1. Introduction

6.2. Predictability of preclinical disease models

6.3. Trends in preclinical drug development

6.4. Relevance of ADME/PK studies

6.5. Experimental tools used in preclinical development

6.6. Drug eliminating agents and mechanisms

6.7. Application of zebrafish as a model whole organism: a landmark in preclinical development

Chapter 7: Animal Utilization in Drug Development: Clinical, Legal, and Ethical Dimensions

Abstract

7.1. Introduction

7.2. The scientific value of animal studies: pharmacology objectives

7.3. Laboratory animals model in the frontiers of drug discovery

7.4. Relationships in animal taxonomy and implications in pharmaceutical research and development

7.5. The effect of species differences on study results

7.6. How reliable is the animal toxicity information generated across the animal species?

7.7. Landmarks in preclinical development: species selection and rationale

7.8. Animal models in the development of biopharmaceuticals: the exceptional use of nonhuman primates

7.9. Legal accommodations on the use of animals in pharmaceutical research and development

7.10. Animal alternatives in drug development: replacing, reducing, and refinement of animals

Chapter 8: Pharmaceutical Formulation and Manufacturing Development: Strategies and Issues

Abstract

8.1. Introduction

8.2. Regulatory aspects of pharmaceutical development

8.3. Formulation and manufacturing in pharmaceutical development

8.4. Clinical trials materials

8.5. Concepts used in pharmaceutical development

8.6. Drug shortages

8.7. Manufacturing problems leading to drug shortages

8.8. Addressing drug shortages: strategies

Section III: The Drug Discovery Cycle II: Clinical Development

Chapter 9: Clinical Development: Ethics and Realities

Abstract

Part I.

Part II. Clinical development of candidate drugs

Part III. Clinical trial ethics

Chapter 10: Pharmacogenomics in Drug Discovery, Prospects and Clinical Applicability

Abstract

10.1. Introduction

10.2. Genetic variations and implications in drug development

10.3. The effectiveness of clinical implementation of pharmacogenomics

10.4. Promising outcomes associated with clinical application pharmacogenomics: cases

10.5. Economic and social implications of pharmacogenomics application

10.6. National regulatory agencies on pharmacogenomics implementation

Section IV: The Drug Discovery Cycle III: Authorization and Marketing

Chapter 11: Patents, Exclusivities, and Evergreening Strategies

Abstract

11.1. Introduction: patents and exclusive marketing rights

11.2. US Patent Law Amendments Act of 1984

11.3. The interplay of patents and exclusivities during the product lifecycle

11.4. Patents in the global pharmaceutical market place

11.5. Evergreening

11.6. Conclusions

Chapter 12: Drug Pricing and Control for Pharmaceutical Drugs

Abstract

12.1. Introduction

12.2. Drug assessment and pricing in various geographical locations

12.3. Pharmaceutical drug pricing and ethics

Chapter 13: Direct-to-Consumer Advertising

Abstract

13.1. Introduction

13.2. Ethics and relevance of pharmaceutical advertising

13.3. Pharmaceutical advertising and government control

13.4. Prescription medicine advertising codes

13.5. Conclusions

People also search for Social Aspects of Drug Discovery Development and Commercialization 1st :

social aspects of drug discovery development and commercialization

importance of drug discovery and development

history of drug discovery and development

what is drug discovery and development

social aspects of drug abuse

Tags: Odilia Osakwe, Syed Rizvi, Social Aspects, Discovery Development